News Tonix launches its new fibromyalgia drug in US Tonix has launched its fibromyalgia therapy Tonmya in the US, the first new drug for the painful condition in more than 16 years.
News Tonix ends 16-year hiatus in fibromyalgia treatment Tonix Pharma is preparing to launch a new therapy for fibromyalgia that analysts predict could make hundreds of millions of dollars in annual sales.
News Arthrosi drug trial in gout delivers for new owner Sobi Sobi's $1.5 billion takeover of Arthrosi at the end of 2025 has started to pay off, with a positive phase 3 trial for gout therapy pozdeutinurad.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
